# Gender-based Differences in the Outcome of Treatment With Aldosterone Antagonists in Patients With Heart Failure

> **NCT06233695** · — · COMPLETED · sponsor: **Alexandria University** · enrollment: 100 (actual)

## Conditions studied

- Heart Failure
- Heart Failure With Reduced Ejection Fraction
- Heart Failure NYHA Class II
- Heart Failure NYHA Class III
- Heart Failure NYHA Class IV

## Interventions

- **DRUG:** Potassium sparing diuretic

## Key facts

- **NCT ID:** NCT06233695
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-15
- **Primary completion:** 2023-07-15
- **Final completion:** 2023-12-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06233695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06233695, "Gender-based Differences in the Outcome of Treatment With Aldosterone Antagonists in Patients With Heart Failure". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06233695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*